There are currently 29 ongoing clinical trials involving Antiphospholipid Syndrome
Of the 29 trials,13 trials are in Phase II
Furthermore, 9 trials are in Phase IV
The global pharmaceutical industry is steadily developing new drugs for Antiphospholipid Syndrome, a Hematological disorder. The highest number of ongoing clinical trials involving Antiphospholipid Syndrome is in Europe. Asia-Pacific and North America are among some of the other prominent regions involved in Antiphospholipid Syndrome-related drug trials.
University of Utah: The leading ongoing Antiphospholipid Syndrome-related clinical trials sponsor
University of Utah, the United States of America-based government institute, is the top sponsor for Antiphospholipid Syndrome-related ongoing clinical trials.
University of Turin, Mansoura University, Nagoya City University Graduate School of Medical Sciences, Nasonova Research Institute of Rheumatology, and Academic Medical Center are a few other notable sponsors involving Antiphospholipid Syndrome.
A clinical trial sponsor can be a Company, Government, Individual, or Institution.
United States of America
China
Switzerland
United States of America
United States of America
United States of America
United States of America
Germany
France
Switzerland
Don’t wait - discover a universe of connected data & insights with your next search. Browse over 28M data points across 22 industries.
Access more premium companies when you subscribe to Explorer
Contact the team or request a demo to find out how our data can drive your business forward